Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis.
(2024)
Journal Article
STOIBER, A., GRAY, G., SAILER, G., HUF, W. and TONNA, A. [2024]. Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis. International journal of clinical pharmacy [online], Latest Articles. Available from: https://doi.org/10.1007/s11096-024-01852-5
Paxlovid® (nirmatrelvir and ritonavir) is the only licensed oral antiviral for COVID-19. Ritonavir is a potent inhibitor of cytochrome P450 enzymes causing numerous drug-drug interactions (DDIs). The aim of this study was to describe the frequency, t... Read More about Frequency, type and severity of drug-related problems and pharmacist interventions in Paxlovid prescribing: a descriptive analysis..